Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

ClinicalTrials.gov ID: NCT04517864

Public ClinicalTrials.gov record NCT04517864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2a, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE SAFETY OF RITLECITINIB (PF-06651600) IN ADULT PARTICIPANTS WITH ALOPECIA AREATA

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a global Phase 2a randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ritlecitinib in adults aged 18 to ≤50 years of age with ≥25% scalp hair loss due to Alopecia Areata (AA).

Study identification

NCT ID
NCT04517864
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
71 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2020 (Actual)
Primary completion
Jan 4, 2022 (Actual)
Completion
May 7, 2024 (Actual)
Last update posted
Jul 11, 2025

2020 – 2024

United States locations

U.S. sites
23
U.S. states
9
U.S. cities
20
Facility City State ZIP Site status
Marvel Clinical Research 002, LLC Huntington Beach California 92647 —
University of California, Irvine Irvine California 92697 —
Skin Care Research, LLC Boca Raton Florida 33486 —
Skin Care Research, LLC Hollywood Florida 33021 —
Kendall Adkisson, MD - Intracoastal Dermatology Jacksonville Florida 32224 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Y&L Advance Health Care Inc., d/b/a Elite Clinical Research Miami Florida 33144 —
BRCR Medical Center Inc Miramar Florida 33027 —
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Orlando Florida 32801 —
Orlando Dermatology & Skin Cancer Surgery Center Oviedo Florida 32765 —
USF Health Morsani Center For Advanced Healthcare Tampa Florida 33612 —
NorthShore University HealthSystem Dermatology Clinical Trials Unit Skokie Illinois 60077 —
NorthShore University HealthSystem Dermatology Clinic Skokie Illinois 60077 —
Washington University School of Medicine-Dermatology St Louis Missouri 63108 —
University of New Mexico Department of Dermatology Albuquerque New Mexico 87102 —
University of New Mexico Clinical & Translational Sciences Center Albuquerque New Mexico 87106 —
Stony Brook Dermatology Stony Brook New York 11790 —
M3 Wake Research, Inc. Raleigh North Carolina 27612 —
Tekton Research, Inc. Austin Texas 78745 —
Center for Clinical Studies, LTD. LLP Houston Texas 77004 —
Summit Clinical Research, LLC Franklin Virginia 23851 —
The Education & Research Foundation, Inc. Lynchburg Virginia 24501 —
Virginia Dermatology and Skin Cancer Center Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04517864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2025 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04517864 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →